Defining the molecular basis of host-pathogen interaction in bovine TB
定义牛结核病宿主与病原体相互作用的分子基础
基本信息
- 批准号:BB/N004574/1
- 负责人:
- 金额:$ 74.87万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2016
- 资助国家:英国
- 起止时间:2016 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The sustainable control of Bovine tuberculosis (bTB) is a major challenge for UK agriculture. bTB is caused by a bacterium, Mycobacterium bovis, that can infect a range of wild and domesticated animals, as well as man. Control of bTB is therefore important for public health as well as animal health and welfare. However, current bTB control measures have been ineffective in the UK. The number of herds newly infected with bTB has doubled every nine years; in 2013 over 6.2 million bTB tests were performed in England leading to the slaughter of over 26,000 cattle at a cost to the taxpayer of almost £100Million. New approaches to halt the spread of infection are desperately needed. Mycobacterium bovis (Mbv) is a close relative of Mycobacterium tuberculosis (Mtb), the causative agent of TB in humans. While some of the mechanisms used by Mtb to cause disease in humans are well characterised, not much is known about the strategies used by Mbv to cause disease in cattle. DNA sequencing of the genomes of Mtb and Mbv have revealed that they share more than 99.9% genetic identity. While both Mbv and Mtb can infect humans, Mbv rarely transmits between humans and is instead spread by contaminated dairy products. On the other hand, Mtb can only cause a mild form of the disease in cattle. The distinct host preference of Mbv and Mtb indicates that the two mycobacterial species have evolved distinct strategies to infect and cause disease in their respective hosts. Through previous studies and our own work, a range of discrete molecular variations have been identified between Mtb and Mbv; these include differences in the expression of proteins, termed MPB70 and MPB83, and lipids, such as 'sulfolipid', between these bacteria. The role of these proteins and lipids in the virulence of Mbv for cattle has however not been defined; in this study we will explore the hypothesis that these molecular differences are among the key reasons why Mbv causes disease in cattle. We will test our hypothesis by first generating genetically-engineered Mbv strains that are 'Mtb-like' with regards to the expression of these lipids and proteins. These strains will then be tested along with their parental Mtb and Mbv strains in cellular infection models. These models will focus on laboratory grown cell cultures of bovine macrophages, cells of the bovine immune system that are the first to encounter and engulf invading Mbv cells. We have initial data to show that these cells respond differently to infection with Mbv and Mtb, and will use the genetically engineered strains of 'Mtb-like' Mbv strains to elucidate the mechanisms used by Mbv to establish infection in cattle. To achieve this we will develop an array of tools and new methodologies, such as the use of fluorescently-labelled Mbv and genetic-knockdown techniques, to study the infected macrophages. These tools will help us monitor critical intracellular components of the macrophage machinery, as well as providing tools for the wider bovine immunology research community. Our findings will shed new light on the molecular components that Mbv uses to cause disease in cattle, information that will help in the long term development of vaccines and diagnostics against this devastating disease for UK agriculture.
牛结核病(bTB)的可持续控制是英国农业面临的重大挑战。bTB是由一种细菌,牛分枝杆菌,可以感染一系列野生和家养动物,以及人。因此,bTB的控制是重要的公共卫生以及动物健康和福利。然而,目前的bTB控制措施在英国无效。新感染bTB的牛群数量每九年翻一番; 2013年,英格兰进行了超过620万次bTB检测,导致超过26,000头牛被屠宰,纳税人花费近1亿英镑。迫切需要新的方法来阻止感染的传播。牛分枝杆菌(Mycobacterium bovis,Mbv)是结核分枝杆菌(Mycobacterium tuberculosis,Mtb)的近亲,结核分枝杆菌是人类结核病的病原体。虽然Mtb用于在人类中引起疾病的一些机制已得到很好的表征,但对Mbv用于在牛中引起疾病的策略知之甚少。Mtb和Mbv基因组的DNA测序显示,它们具有超过99.9%的遗传同一性。虽然Mbv和Mtb都可以感染人类,但Mbv很少在人类之间传播,而是通过受污染的乳制品传播。另一方面,Mtb只能在牛中引起轻微形式的疾病。Mbv和Mtb的不同宿主偏好表明这两种分枝杆菌物种已经进化出不同的策略来感染各自的宿主并在其各自的宿主中引起疾病。通过以前的研究和我们自己的工作,Mtb和Mbv之间已经确定了一系列离散的分子变异;这些包括蛋白质表达的差异,称为MPB 70和MPB 83,以及这些细菌之间的脂质,如“sulfolipid”。然而,这些蛋白质和脂质在Mbv对牛的毒力中的作用尚未确定;在本研究中,我们将探讨这些分子差异是Mbv引起牛疾病的关键原因的假设。我们将通过首先产生在这些脂质和蛋白质的表达方面是“Mtb样”的基因工程Mbv菌株来测试我们的假设。然后在细胞感染模型中对这些菌株及其亲本Mtb和Mbv菌株进行沿着检测。这些模型将集中在实验室培养的牛巨噬细胞,牛免疫系统的细胞,是第一个遇到和吞噬入侵的Mbv细胞。我们有初步数据表明,这些细胞对Mbv和Mtb感染的反应不同,并将使用“Mtb样”Mbv菌株的基因工程菌株来阐明Mbv在牛中建立感染的机制。为了实现这一目标,我们将开发一系列工具和新方法,例如使用荧光标记的Mbv和遗传敲低技术来研究受感染的巨噬细胞。这些工具将帮助我们监测巨噬细胞机器的关键细胞内成分,并为更广泛的牛免疫学研究社区提供工具。我们的研究结果将为Mbv用于引起牛疾病的分子组分提供新的信息,这些信息将有助于长期开发针对这种毁灭性疾病的疫苗和诊断方法。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Transposon libraries identify novel Mycobacterium bovis BCG genes involved in the dynamic interactions required for BCG to persist during in vivo passage in cattle.
转座子文库鉴定出新的牛分枝杆菌 BCG 基因,这些基因涉及 BCG 在牛体内传代过程中持续存在所需的动态相互作用。
- DOI:10.1186/s12864-019-5791-1
- 发表时间:2019
- 期刊:
- 影响因子:4.4
- 作者:Mendum TA
- 通讯作者:Mendum TA
Insights into the ancestry evolution of the Mycobacterium tuberculosis complex from analysis of Mycobacterium riyadhense.
- DOI:10.1093/nargab/lqab070
- 发表时间:2021-09
- 期刊:
- 影响因子:4.6
- 作者:Guan Q;Garbati M;Mfarrej S;AlMutairi T;Laval T;Singh A;Fagbo S;Smyth A;Browne JA;urRahman MA;Alruwaili A;Hoosen A;Meehan CJ;Nakajima C;Suzuki Y;Demangel C;Bhatt A;Gordon SV;AlAsmari F;Pain A
- 通讯作者:Pain A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Apoorva Bhatt其他文献
MtrA modulates emMycobacterium tuberculosis/em cell division in host microenvironments to mediate intrinsic resistance and drug tolerance
MtrA 调节结核分枝杆菌在宿主微环境中的细胞分裂,以介导内在抗性和耐药性
- DOI:
10.1016/j.celrep.2023.112875 - 发表时间:
2023-08-29 - 期刊:
- 影响因子:6.900
- 作者:
Eliza J.R. Peterson;Aaron N. Brooks;David J. Reiss;Amardeep Kaur;Julie Do;Min Pan;Wei-Ju Wu;Robert Morrison;Vivek Srinivas;Warren Carter;Mario L. Arrieta-Ortiz;Rene A. Ruiz;Apoorva Bhatt;Nitin S. Baliga - 通讯作者:
Nitin S. Baliga
3D printed microcrystalline CsI:Tl composite scintillating thin films for X-ray imaging
- DOI:
10.1016/j.radmeas.2024.107301 - 发表时间:
2024-11-01 - 期刊:
- 影响因子:
- 作者:
Divya Pandya;Nisha Oad;Sheetal Rawat;Brijesh Tripathi;Pavan Gurrala;Partha Sarathi Sarkar;Mohit Tyagi;Apoorva Bhatt - 通讯作者:
Apoorva Bhatt
Specific activation of murine and human NKT cells with cholesteryl glycosides produced by Helicobacter pylori
利用幽门螺杆菌产生的胆固醇糖苷特异性激活小鼠和人类 NKT 细胞
- DOI:
- 发表时间:
2009 - 期刊:
- 影响因子:0
- 作者:
Michio Shimamura;Petr Illarionov;Shin Endo;Yi-Ying Huang;Abel Singh;Apoorva Bhatt;Gurdayl S. Besra;Janneke Maaskant;Ben J. Appelmelk;Hye Young Kim;Muriel Pichavant;Dale T. Umetsu - 通讯作者:
Dale T. Umetsu
Analysis of Mechanical Properties of Nano Molybdenum And Nano Nickel Using High Pressure Equation of State
利用高压状态方程分析纳米钼和纳米镍的力学性能
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
N. A. Thakar;Apoorva Bhatt;T. C. Pandya - 通讯作者:
T. C. Pandya
The role of ABC transporter DrrABC in the export of PDIM in <em>Mycobacterium tuberculosis</em>
- DOI:
10.1016/j.tcsw.2024.100132 - 发表时间:
2024-12-01 - 期刊:
- 影响因子:
- 作者:
Nabiela Moolla;Helen Weaver;Rebeca Bailo;Albel Singh;Vassiliy N. Bavro;Apoorva Bhatt - 通讯作者:
Apoorva Bhatt
Apoorva Bhatt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Apoorva Bhatt', 18)}}的其他基金
Mechanisms Of Mycolic Acid Generation In Mycobacteria
分枝杆菌中分枝菌酸的产生机制
- 批准号:
BB/Y006593/1 - 财政年份:2024
- 资助金额:
$ 74.87万 - 项目类别:
Research Grant
India Partnering Award: Exploiting the microbial diversity of the Sundarbans mangrove delta to tackle infectious disease
印度合作奖:利用孙德尔本斯红树林三角洲的微生物多样性来应对传染病
- 批准号:
BB/S020659/1 - 财政年份:2019
- 资助金额:
$ 74.87万 - 项目类别:
Research Grant
14 NSFBIO:Identifying Mechanisms for Environmental Adaptation in CMNR Bacteria: A Systems Analysis of GeneRegulation of AlternativeSubstrateMetabolism
14 NSFBIO:识别 CMNR 细菌环境适应机制:替代底物代谢基因调控的系统分析
- 批准号:
BB/N01314X/1 - 财政年份:2015
- 资助金额:
$ 74.87万 - 项目类别:
Research Grant
Deciphering mycolic acid transport in Mycobacterium tuberculosis
破译结核分枝杆菌中分枝菌酸的转运
- 批准号:
MR/K00042X/1 - 财政年份:2013
- 资助金额:
$ 74.87万 - 项目类别:
Research Grant
Mycolic acid biosynthesis and processing in Mycobacterium tuberculosis
结核分枝杆菌中分枝菌酸的生物合成和加工
- 批准号:
G0600105/1 - 财政年份:2006
- 资助金额:
$ 74.87万 - 项目类别:
Fellowship
相似国自然基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
- 批准号:82371616
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
- 批准号:82370981
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
- 批准号:82372073
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
- 批准号:82371652
- 批准年份:2023
- 资助金额:45.00 万元
- 项目类别:面上项目
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
- 批准号:82373145
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
- 批准号:82304565
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
- 批准号:82372328
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Irisin通过整合素调控黄河鲤肌纤维发育的分子机制研究
- 批准号:32303019
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
- 批准号:82371704
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
上皮细胞黏着结构半桥粒在热激保护中的作用机制研究
- 批准号:31900545
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Defining the molecular basis of chloroplast transcription of photosynthetic genes
定义光合基因叶绿体转录的分子基础
- 批准号:
BB/Y003802/1 - 财政年份:2024
- 资助金额:
$ 74.87万 - 项目类别:
Research Grant
Defining the neural basis for persistent obesity
定义持续性肥胖的神经基础
- 批准号:
10735128 - 财政年份:2023
- 资助金额:
$ 74.87万 - 项目类别:
Determining the molecular basis of gene silencing by MucR and defining its role in Brucella virulence
确定 MucR 基因沉默的分子基础并确定其在布鲁氏菌毒力中的作用
- 批准号:
10732605 - 财政年份:2023
- 资助金额:
$ 74.87万 - 项目类别:
Defining the molecular basis for Salmonella persistence
定义沙门氏菌持久性的分子基础
- 批准号:
DP230102796 - 财政年份:2023
- 资助金额:
$ 74.87万 - 项目类别:
Discovery Projects
Defining the molecular and anatomical basis of the blood-olfactory barrier (BOB)
定义血嗅屏障(BOB)的分子和解剖学基础
- 批准号:
10723087 - 财政年份:2023
- 资助金额:
$ 74.87万 - 项目类别:
Defining the cell and molecular basis of Toxoplasma recrudescence
定义弓形虫复发的细胞和分子基础
- 批准号:
10330031 - 财政年份:2021
- 资助金额:
$ 74.87万 - 项目类别:
Defining the molecular basis of oncogene-induced replication stress
定义癌基因诱导的复制应激的分子基础
- 批准号:
10515661 - 财政年份:2021
- 资助金额:
$ 74.87万 - 项目类别:
Defining the molecular basis controlling hematopoietic stem cell symmetric and asymmetric divisions -supplement
定义控制造血干细胞对称和不对称分裂的分子基础 - 补充
- 批准号:
10765290 - 财政年份:2021
- 资助金额:
$ 74.87万 - 项目类别:
Defining the molecular basis controlling hematopoietic stem cell symmetric and asymmetric divisions
定义控制造血干细胞对称和不对称分裂的分子基础
- 批准号:
10468013 - 财政年份:2021
- 资助金额:
$ 74.87万 - 项目类别:
Defining the cell and molecular basis of Toxoplasma recrudescence
定义弓形虫复发的细胞和分子基础
- 批准号:
10180280 - 财政年份:2021
- 资助金额:
$ 74.87万 - 项目类别: